Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Influenza Vaccination | Research article

Influenza vaccination among children with idiopathic nephrotic syndrome: an investigation of practices

Authors: Roman Klifa, Julie Toubiana, Alizée Michel, Nathalie Biebuyck, Marina Charbit, Laurence Heidet, Saoussen Krid, Pauline Krug, Rémi Salomon, Olivia Boyer

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Annual influenza vaccination is recommended for all children with idiopathic nephrotic syndrome (INS) in France. Consequently, the Social Security automatically sends prescriptions to all patients suffering from a chronic disease. The aim of this study was to evaluate the follow-up to these recommendations.

Methods

We conducted a monocentric retrospective investigation of practices. We included all children with steroid-sensitive INS in remission who attended our clinics from January 1st 2015 to January 1st 2017, resided in France and had a valid phone number. Data were collected from May 2017 to June 2017 through a phone interview and review of clinical charts.

Results

75 patients met the inclusion criteria. The parents of 57 children could be reached by phone and agreed to participate to the survey. 35/57 (61.4%) declared having received a prescription during the 2016–2017 campaign. Only 14 children (24.6%) were vaccinated. 17/43 (39.5%) parents of unvaccinated children had concerns about the safety of the vaccine, 16/43 (37.2%) were not aware of the recommendations, 5/43 (11.6%) had been recommended by their physician not to vaccinate their child, 3/43 (7%) forgot to have them vaccinated and 2/43 (4.6%) reported no reason. 13/43 (30%) unvaccinated children presented a relapse during the flu season - 2/13 during an influenza-like illness - whereas 1/14 (7%) immunized children presented a relapse during the six months of post-vaccination follow-up. Relapse rates were not increased in vaccinated children compared to unvaccinated children (p = 0.15), nor in the 6 months following vaccination compared to the 6 months prior (1/14 vs 5/14, p = 0.20).

Conclusions

1) < 2/3 patients were properly prescribed the recommended yearly influenza vaccination at our center 2) only 1/4 were vaccinated and most of their parents were misinformed. Physicians must be aware of this and should make every effort to better inform their patients on the risks of flu illness and the benefits and safety of the vaccination.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dossier C, Lapidus N, Bayer F, et al. Epidemiology of idiopathic nephrotic syndrome in children: endemic or epidemic? Pediatr Nephrol Berl Ger. 2016;31:2299–308.CrossRef Dossier C, Lapidus N, Bayer F, et al. Epidemiology of idiopathic nephrotic syndrome in children: endemic or epidemic? Pediatr Nephrol Berl Ger. 2016;31:2299–308.CrossRef
2.
go back to reference Grupe WE. Childhood nephrotic syndrome: clinical associations and response to therapy. Postgrad Med. 1979;65:229–36.CrossRef Grupe WE. Childhood nephrotic syndrome: clinical associations and response to therapy. Postgrad Med. 1979;65:229–36.CrossRef
3.
go back to reference Schnaper HW. The immune system in minimal change nephrotic syndrome. Pediatr Nephrol. 1989;3:101–10.CrossRef Schnaper HW. The immune system in minimal change nephrotic syndrome. Pediatr Nephrol. 1989;3:101–10.CrossRef
4.
go back to reference Lin C-Y, Hsu H-C. Histopathological and immunological studies in spontaneous remission of nephrotic syndrome after Intercurrent measles infection. Nephron. 1986;42:110–5.CrossRef Lin C-Y, Hsu H-C. Histopathological and immunological studies in spontaneous remission of nephrotic syndrome after Intercurrent measles infection. Nephron. 1986;42:110–5.CrossRef
7.
go back to reference Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003–2004. N Engl J Med. 2005;353:2559–67.CrossRef Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003–2004. N Engl J Med. 2005;353:2559–67.CrossRef
8.
go back to reference Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL. Idiopathic Nephrotic Syndrome in Children: Clinical Aspects. In: Niaudet P, Boyer O, editors. Pediatric Nephrology. 7th ed. Berlin Heidelberg: Springer-Verlag; 2016. Available at: //www.springer.com/in/book/9783662435953. Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL. Idiopathic Nephrotic Syndrome in Children: Clinical Aspects. In: Niaudet P, Boyer O, editors. Pediatric Nephrology. 7th ed. Berlin Heidelberg: Springer-Verlag; 2016. Available at: //www.​springer.​com/​in/​book/​9783662435953.
10.
go back to reference Ulinski T, Leroy S, Dubrel M, Danon S, Bensman A. High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone. Pediatr Nephrol. 2008;23:1107–13.CrossRef Ulinski T, Leroy S, Dubrel M, Danon S, Bensman A. High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone. Pediatr Nephrol. 2008;23:1107–13.CrossRef
12.
go back to reference Fiore AE, Shay DK, Broder K, et al. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP), 2008. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 2008;57:1–60. Fiore AE, Shay DK, Broder K, et al. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP), 2008. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 2008;57:1–60.
13.
go back to reference Jackson ML, Chung JR, Jackson LA, et al. Influenza vaccine effectiveness in the United States during the 2015–2016 season. N Engl J Med. 2017;377:534–43.CrossRef Jackson ML, Chung JR, Jackson LA, et al. Influenza vaccine effectiveness in the United States during the 2015–2016 season. N Engl J Med. 2017;377:534–43.CrossRef
15.
go back to reference Gangarosa EJ, Galazka AM, Wolfe CR, et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet Lond Engl. 1998;351:356–61.CrossRef Gangarosa EJ, Galazka AM, Wolfe CR, et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet Lond Engl. 1998;351:356–61.CrossRef
16.
go back to reference Wolfe RM, Sharp LK, Lipsky MS. Content and design attributes of Antivaccination web sites. JAMA. 2002;287:3245–8.CrossRef Wolfe RM, Sharp LK, Lipsky MS. Content and design attributes of Antivaccination web sites. JAMA. 2002;287:3245–8.CrossRef
17.
go back to reference Poland GA, Jacobson RM. The age-old struggle against the Antivaccinationists. N Engl J Med. 2011;364:97–9.CrossRef Poland GA, Jacobson RM. The age-old struggle against the Antivaccinationists. N Engl J Med. 2011;364:97–9.CrossRef
18.
go back to reference Peretti-Watel P, Verger P, Raude J, et al. Dramatic change in public attitudes towards vaccination during the 2009 influenza a (H1N1) pandemic in France. Eurosurveillance. 2013;18:20623.CrossRef Peretti-Watel P, Verger P, Raude J, et al. Dramatic change in public attitudes towards vaccination during the 2009 influenza a (H1N1) pandemic in France. Eurosurveillance. 2013;18:20623.CrossRef
19.
go back to reference Larson HJ, de Figueiredo A, Xiahong Z, et al. The state of vaccine confidence 2016: global insights through a 67-country survey. EBioMedicine. 2016;12:295–301.CrossRef Larson HJ, de Figueiredo A, Xiahong Z, et al. The state of vaccine confidence 2016: global insights through a 67-country survey. EBioMedicine. 2016;12:295–301.CrossRef
21.
go back to reference Massin S, Ventelou B, Nebout A, Verger P, Pulcini C. Cross-sectional survey: risk-averse French general practitioners are more favorable toward influenza vaccination. Vaccine. 2015;33:610–4.CrossRef Massin S, Ventelou B, Nebout A, Verger P, Pulcini C. Cross-sectional survey: risk-averse French general practitioners are more favorable toward influenza vaccination. Vaccine. 2015;33:610–4.CrossRef
22.
go back to reference Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis. 2009;199:159–67.CrossRef Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis. 2009;199:159–67.CrossRef
23.
go back to reference DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371:635–45.CrossRef DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371:635–45.CrossRef
24.
go back to reference Jackson ML, Jackson LA, Kieke B, et al. Incidence of medically attended influenza infection and cases averted by vaccination, 2011/12 and 2012/13 influenza seasons. Vaccine. 2015;33:5181–7.CrossRef Jackson ML, Jackson LA, Kieke B, et al. Incidence of medically attended influenza infection and cases averted by vaccination, 2011/12 and 2012/13 influenza seasons. Vaccine. 2015;33:5181–7.CrossRef
25.
go back to reference McLean HQ, Thompson MG, Sundaram ME, et al. Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type. J Infect Dis. 2015;211:1529–40.CrossRef McLean HQ, Thompson MG, Sundaram ME, et al. Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type. J Infect Dis. 2015;211:1529–40.CrossRef
26.
go back to reference Anon. flu-03-ferdinands.pdf. Available at: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2017-06/flu-03-ferdinands.pdf. Accessed Mar 13, 2018. Anon. flu-03-ferdinands.pdf. Available at: https://​www.​cdc.​gov/​vaccines/​acip/​meetings/​downloads/​slides-2017-06/​flu-03-ferdinands.​pdf.​ Accessed Mar 13, 2018.
27.
go back to reference Flannery B, Reynolds SB, Blanton L, et al. Influenza vaccine effectiveness against pediatric deaths: 2010–2014. Pediatrics. 2017;139:e20164244.CrossRef Flannery B, Reynolds SB, Blanton L, et al. Influenza vaccine effectiveness against pediatric deaths: 2010–2014. Pediatrics. 2017;139:e20164244.CrossRef
28.
go back to reference Poyrazoglu HM, Düsünsel R, Gündüz Z, Patiroglu T, Köklü S. Antibody response to influenza a vaccination in children with nephrotic syndrome. Pediatr Nephrol. 2004;19:57–60.CrossRef Poyrazoglu HM, Düsünsel R, Gündüz Z, Patiroglu T, Köklü S. Antibody response to influenza a vaccination in children with nephrotic syndrome. Pediatr Nephrol. 2004;19:57–60.CrossRef
29.
go back to reference Alpay H, Yıldız N, Onar A, Temizer H, Özçay S. Varicella vaccination in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2002;17:181–3.CrossRef Alpay H, Yıldız N, Onar A, Temizer H, Özçay S. Varicella vaccination in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2002;17:181–3.CrossRef
30.
go back to reference Pittet LF, Posfay-Barbe KM, Chehade H, et al. Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccine. Vaccine. 2016;34:4948–54.CrossRef Pittet LF, Posfay-Barbe KM, Chehade H, et al. Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccine. Vaccine. 2016;34:4948–54.CrossRef
31.
go back to reference Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI. Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. Vaccine. 2014;32:1394–7.CrossRef Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI. Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. Vaccine. 2014;32:1394–7.CrossRef
32.
go back to reference Sheth KJ, Sedmak GV, Freeman ME, Eisenberg C. Hemagglutination-lnhibiting antibodies in vaccinated children with renal disease. JAMA. 1979;242:1752–4.CrossRef Sheth KJ, Sedmak GV, Freeman ME, Eisenberg C. Hemagglutination-lnhibiting antibodies in vaccinated children with renal disease. JAMA. 1979;242:1752–4.CrossRef
33.
go back to reference Abeyagunawardena AS, Goldblatt D, Andrews N, Trompeter RS. Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Lancet Lond Engl. 2003;362:449–50.CrossRef Abeyagunawardena AS, Goldblatt D, Andrews N, Trompeter RS. Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Lancet Lond Engl. 2003;362:449–50.CrossRef
34.
go back to reference Yıldız N, Sever L, Kasapçopur ö, Çullu F, Arısoy N, Çalışkan S. Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: immunogenicity and safety? Vaccine. 2013;31:3309–12.CrossRef Yıldız N, Sever L, Kasapçopur ö, Çullu F, Arısoy N, Çalışkan S. Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: immunogenicity and safety? Vaccine. 2013;31:3309–12.CrossRef
35.
go back to reference Taylor B, Andrews N, Stowe J, Hamidi-Manesh L, Miller E. No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Arch Dis Child. 2007;92:887–9.CrossRef Taylor B, Andrews N, Stowe J, Hamidi-Manesh L, Miller E. No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Arch Dis Child. 2007;92:887–9.CrossRef
Metadata
Title
Influenza vaccination among children with idiopathic nephrotic syndrome: an investigation of practices
Authors
Roman Klifa
Julie Toubiana
Alizée Michel
Nathalie Biebuyck
Marina Charbit
Laurence Heidet
Saoussen Krid
Pauline Krug
Rémi Salomon
Olivia Boyer
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1240-2

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue